Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Plasma cell
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Clinical significance== [[Plasmacytoma]], [[multiple myeloma]], [[Waldenström macroglobulinemia]], [[heavy chain disease]], and [[plasma cell leukemia]] are [[cancer]]s of the plasma cells.<ref>{{DorlandsDict|nine/000951264|Plasma cell}}</ref> Multiple myeloma is frequently identified because malignant plasma cells continue producing an antibody, which can be detected as a [[paraprotein]]. [[Monoclonal gammopathy of undetermined significance|Monoclonal gammopathy of undetermined significance (MGUS)]] is a plasma cell dyscrasia characterized by the secretion of a myeloma protein into the blood and may lead to multiple myeloma.<ref>{{Cite journal |last1=Agarwal |first1=Amit |last2=Ghobrial |first2=Irene M. |date=2013-03-01 |title=Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease |journal=Clinical Cancer Research|volume=19 |issue=5 |pages=985–994 |doi=10.1158/1078-0432.CCR-12-2922 |issn=1557-3265 |pmc=3593941 |pmid=23224402}}</ref> [[Common variable immunodeficiency]] is thought to be due to a problem in the [[cellular differentiation|differentiation]] from lymphocytes to plasma cells. The result is a low serum antibody level and risk of infections.{{cn|date=May 2024}} [[AL amyloidosis|Primary amyloidosis (AL)]] is caused by the deposition of excess immunoglobulin light chains which are secreted from plasma cells.{{cn|date=May 2024}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)